Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > P.T. The bag will heal people
View:
Post by Charly50 on Dec 01, 2021 5:20am

P.T. The bag will heal people

As Philipp Toleikis, CEO of Sernova, himself indicates, there will probably be a licensing deal. Numerous conditions and details have to be worked out to ensure legal certainty for both parties.  In my opinion, we now seem to be in this decisive phase of negotiations, in which the lawyers and notaries of the contracting parties are busy with the signing of the contract. 
 
According to the CEO PHILIP TOLEIKIS:
1.the bag is safe 
The bag will heal people,
 
which should be considered as a medical revolution.
 
---- and more. I think that behind the scenes already with a 
"Medtech company" the distribution network is being built.
 
There is speculation about which big pharma company might be in line for a deal. For years Sernova has cherished the cooperation with:  Medtronic.
 
Source: Sernova Corp February 22, 2018, 6:00 a.m. EDT
 
LONDON, ONTARIO - (Globe Newswire - February 22, 2018) - Sernova Corp. (TSX-V: SVA) (OTCQB: SEOVF) (FSE: PSH), a clinical stage company developing regenerative medicine technologies for the treatment of chronic diseases including diabetes and hemophilia, is pleased to announce continuous glucose monitoring systems (CGM (Medtronic Minimed, Northridge, CA)) will be provided to patients in Sernova's US regenerative medicine clinical trial of its Cell Pouch(TM). CGM will be used to track the function of the transplanted cells in the measurement of key efficacy measures at multiple time points following transplantation of the therapeutic cells into the Cell Pouch.
As Redbaron correctly pointed out
the only thing that can be blamed on Philip Toleikis is the assessment of the time point of the licensing deal.
If one wants to defend him, one has to consider the above mentioned points, that a license deal is more difficult than a takeover and many, many details have to be considered and clarified. After all, there is a lot of money at stake.
I remain very optimistic and believe that we will receive the long-awaited news very soon.
 
*my very personal opinion!!
 
 
Comment by Ekenbullets on Dec 01, 2021 12:04pm
I think market have very little believe in statements from Philip or else we would not be sinking to Dear old 1.20 when he has indicated a game changing deal is on the way. I remember he said like a year ago that he wanted Sernova to remain canadian. I think his priorities are not the same as short term investors. He wants to cure diabetes typ 1. Its a nobel prize potential om that and he will be ...more  
Comment by Metalsguy1 on Dec 01, 2021 12:20pm
Send in the clown.....don't bother he's here.
Comment by MoneyMouth on Dec 01, 2021 1:27pm
Hi clown!
Comment by Metalsguy1 on Dec 03, 2021 11:29am
aww Moneymouth..did your knee pads finally wear out?
Comment by MoneyMouth on Dec 03, 2021 1:17pm
Nice comeback
Comment by Markhamjohn on Dec 02, 2021 8:24pm
l have been away from this board for some time and so please forgive if this has already been discussed. The disappointment about SP appreciation seems to be tempered with the general feeling that a licensing deal might happen. Would anyone care to speculate what kind of an affect that a licensing deal would have on the share price - let's say, over the next 4 months?
Comment by Redbaron2211 on Dec 03, 2021 1:29am
It is relevant that Frank has done very little for the company up until this point.  It shows something fundamental is changing within the company.  He co founded Angiotech, ID Biomedical, Xenon Pharma. He wouldn't be investing time here unless a licensing deal or some other catalyst was about to come to fruition adding another multi billion dollar company to his list.    ...more  
Comment by BioTeck on Dec 03, 2021 1:52am
Goodluck. Not with with the current ringmaster and circus clowns. Also rixy you do realize 1.55 to 1.25 is about 25 percent.
Comment by rixpix on Dec 03, 2021 1:42pm
Agree with BioTeck here. No way will I believe SVA can go 3x higher within the next 4 months. I'll be happy if we double within the next 12 months.  And yes, Bio, I know very well what 1.25 to 1.55 is in percentages. For dollar stocks with low volume going up or down a dime is nothing. If it was $12.50 - $15.50 the increase or drop would be seen differently although the percentage would ...more  
Comment by Charly50 on Dec 03, 2021 7:50am
Yes, thats wright
Comment by Metalsguy1 on Dec 03, 2021 11:35am
Mark... the share price will tank. Did you ask that question seriously? Obviously it depends on the terms of the deal but rest assured any rise will be tempered by Holler wallowing in the stock option pool.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities